Our mission is to provide customized surface technology solutions by combining best-in-class quality and customer service to support the development of medical devices that aid in improving patient outcomes.

We are a global leader in the development, manufacturing and application of hydrophilic (slippery) coatings used in medical devices. Our hydrophilic coatings allow for medical devices to easily transverse through the body by minimizing friction as the material moves to its intended destination. Our custom hydrophilic coatings are lubricious, abrasion resistant, biocompatible and can be applied to a wide range of polymeric and metallic substrates.

1
Years of partnership
1
Countries covered worldwide
2016
ISO 13485:2016 Certified

Facilities & Locations

 

Biocoat’s headquarters are located in Horsham, PA, about 45 minutes outside of Philadelphia, PA. In May 2018, Biocoat officially opened our new facility at Rock Road, bringing our total square footage to 62,000 square feet. Biocoat has four Class 7 clean rooms, manufacturing, R&D and disaster recovery facilities all dedicated to the development and expert application of our hydrophilic coatings.

GET OUR ADDRESS & CONTACT INFORMATION

Our Leadership

The strength of an organization lies in its people. The team of experts at Biocoat, and its Board of Directors, is made up of leaders in the industry, clinical champions and innovative thinkers.

Leadership Team

Jim Moran
President & CEO

Read Bio »

Steven Bell
Chief Financial Officer

Read Bio »

Peg Beavers
Executive Vice President

Read Bio »

Joe Sandora
Vice President, Business Development

Read Bio »

Dr. Robert Hergenrother
Vice President, Research, Development and Innovation

Read Bio »

Thomas Brugnoli
Senior Director of Operations

Read Bio »

Dhruv Patel
Senior Director, Applications Development & Technical Services

Read Bio »

Heather L.A. Hennessey
Director, Quality Assurance & Regulatory Affairs

Read Bio »

Board of Directors

Scott Cramer
Chairman of the Board
President & CEO, DNA Diagnostics Center

Read Bio »

Michael Koby
Founding Partner, 1315 Capital

Read Bio »

Matt Bastardi
SVP, Commercial & Strategy, Surgical Specialties Corporation

Read Bio »

Wes Kaupinen
President and CEO, Palvella Therapeutics

Read Bio »

Jim Moran
President & CEO, Biocoat

Read Bio »

A Legacy of Innovation

2021
Celebrating our 30th year of developing hydrophilic coatings!

Celebrating our 30th year of developing hydrophilic coatings!

2020
Introduction of HYDAK<sup>®</sup> UV

Introduction of HYDAK® UV

Biocoat introduces a new UV cured version of our HYDAK coatings.

2019
Grand Opening of Coating Services Unit

Grand Opening of Coating Services Unit

To read more about our Coating Services, visit our Custom Coating Solutions section in the main navigation.

2019
ISO Certified

ISO Certified

Biocoat receives its ISO 13485:2016 certification.

2018
1315 Capital Acquires Biocoat

1315 Capital Acquires Biocoat

Biocoat celebrates its renewed mission to offer industry-leading custom coating solutions with its acquisition by 1315 Capital.

2018
Grand Opening & a Renewed Mission

Grand Opening & a Renewed Mission

The Rock Road facility opens, bringing the company’s total square footage to over 62,000 square feet.

2017
A Brand New Look

A Brand New Look

Biocoat undergoes a complete rebranding, better reflecting the cutting-edge technology they offer their medical device partners.

2016
Groundbreaking on a New Home

Groundbreaking on a New Home

Construction of Biocoat’s state-of-the-art Rock Road headquarters begins in Horsham, PA. The new facility, in combination with the original Witmer Road facility, means over 62,000 square feet of production capacity.

2007
PICSI<sup>®</sup> Device Released

PICSI® Device Released

Biocoat releases the revolutionary PICSI® Sperm Selection Device.

2005
The Move to Horsham

The Move to Horsham

Biocoat’s headquarters officially moves from Beaver College to its new home on Witmer Road in Horsham, PA.

2004
HBA<sup>®</sup> Released

HBA® Released

Biocoat’s proprietary Hyaluronan Binding Assay (HBA) is released to the medical device market.

2003
An End of an Era

An End of an Era

Ellington Beavers, visionary and founder of Biocoat, retires.

1994
First Products are Licensed

First Products are Licensed

Two companies license Biocoat products for commercial use.

1991
Company is Founded

Company is Founded

By Ellington Beavers at Beaver College (present day Arcadia University)

Want to talk to one of our experts about your project? Submit this form to request a consult.

    Back To Top

    Heather L.A. Hennessey

    Director of Quality Assurance & Regulatory Affairs, and Management Representative

    Heather L.A. Hennessey is the Director of Quality Assurance & Regulatory Affairs, and Management Representative for Biocoat. In her role, Heather is responsible for oversight of the Quality Assurance and Quality Control groups, as well as ensuring overall quality and regulatory compliance for the entire organization.

    Heather joined Biocoat in 2020 and has a 20 year track record of success in compliance remediation, driving out inefficiencies, and implementing change and continuous improvement at such companies as Polysciences, Regeneron, The Secant Group, Cenveo, AstraZeneca (Medimmune), and Day & Zimmermann International.

    Heather received a Bachelor of Science in Biology from Stockton University and is a certified ISO 13485:2016 Lead Auditor.

    Wes Kaupinen

    President and CEO, Palvella Therapeutics

    Wes Kaupinen has been on the Biocoat Board since 2017 and is the President and CEO of Palvella Therapeutics. Wes has an extensive background in M&A, business development, and capital raising, having spent time an as investment banker, venture capital investor and senior executive at a publicly traded life sciences company. Wes has extensive networks in the cardiovascular, neurovascular, peripheral vascular, ophthalmic markets as well as in the private equity arena.

    Wes has an MBA degree from the Wharton School at University of Pennsylvania and a B.A. from the University of Virginia.

    Matt Bastardi

    SVP, Commercial & Strategy, Surgical Specialties Corporation

    Matt has held senior level positions within multi-national and emerging growth medical device & diagnostics companies. His experience spans corporate development, strategic planning, sales, marketing, finance, and general management leadership roles for branded products and contract manufacturing businesses.

    Currently, he is Senior Vice President, Commercial & Strategy for Surgical Specialties Corporation. Previously, Matt held various positions with Accriva Diagnostics, Covidien, Flex, and Accellent.

    Matt earned an MBA from the Kellogg School of Management at Northwestern University, and a Bachelor of Science degree in Business from Georgetown University.

    Michael Koby

    Founding Partner, 1315 Capital

    Michael Koby co-founded 1315 Capital in 2014, after spending his entire career as a healthcare investor and operator, including experience with more than 25 growth equity investments. Prior to founding 1315 Capital, Michael was a Managing Director at Palm Ventures, a private-equity focused family office where he led all healthcare investing. While at Palm, Michael led investments in Enigma Diagnostics, Axcentria Pharmaceuticals, and JDS Therapeutics. He currently serves on the boards of Biocoat, Centurion Service Group, CHC Solutions, JDS Therapeutics, and Solsys Medical.

    Before Palm Ventures, Michael spent over a decade as an investor, including before and after business school, at Galen Partners, a healthcare growth equity investment firm. He also held business development roles at Novoste Corporation and Medtronic, Inc. Michael started his career as a healthcare investment banking analyst at Dillon, Read & Co.

    Michael received a BSc from Cornell University and an MBA in Healthcare Management from The Wharton School.

    Scott Cramer

    Chairman of the Board
    President & CEO, DNA Diagnostics Center

    Scott has over 30 years’ experience and is a proven and focused medical device & diagnostics CEO. He has significant experience driving change by instilling a culture of high performance and implementing growth strategies as well as operational improvement initiatives, resulting in a track-record of successful exits.

    Scott has served in executive level positions at Accriva Diagnostics, Warburg Pincus, Novasys Medical, Bacchus Vascular, VNUS Medical, EndoSonics (Volcano Corporation), Cardiometrics and Baxter Healthcare Corporation.

    Scott holds a B.S. degree in Finance from Philadelphia University.

    Thomas Brugnoli

    Senior Director of Operations

    Thomas (Tom) Brugnoli is Biocoat’s Senior Director of Operations. Tom joined Biocoat in 2019 to lead the design and management of the Contract Coating Services unit. Tom is also responsible for the manufacturing of all coating reagents.

    Tom has over 30 years of manufacturing experience which he obtained from prior operations, manufacturing and engineering services positions at Bristol-Myers Squibb and ConvaTec.

    Dhruv Patel

    Senior Director, Technical Sales & Services

    Dhruv Patel is the Senior Director of Applications Development & Technical Services for Biocoat. In this role, Dhruv is responsible for assisting Biocoat’s customers during the testing, implementation and launch of medical device products that require the use of hydrophilic coatings.

    Dhruv joined Biocoat in 2009 and holds a Bachelor of Science degree from the University of Mumbai, and two Masters degrees, one in Biomedical Engineering from the New Jersey Institute of Technology and the other in Business Administration from Villanova University.

    Dr. Robert Hergenrother

    Vice President of Research, Development and Innovation

    Dr. Robert (Bob) Hergenrother is Biocoat’s Vice President of Research, Development and Innovation. In this role, Bob leads the research team in the development, maximization and exploration of new products and coating methodologies.

    Bob joined Biocoat in 2017 after spending nearly 25 years in research and development roles at the Southern Research Institute, Surmodics and Boston Scientific. Bob was also a Professor in the Department of Biomedical Engineering at the University of Alabama at Birmingham.

    Bob holds a Bachelor of Science degree from the University of Notre Dame and a PhD in Chemical Engineering from the University of Wisconsin-Madison.

    Joe Sandora

    Vice President, Business Development

    Joe Sandora joined Biocoat in 2018 as Vice President of Business Development. In his role, Joe has been responsible for all domestic and international strategic relationships, contract negotiations and corporate sales strategy.

    He has over 25 years in business development and senior sales management in the medical device industry having previously been with Devon Medical Products, Georgia-Pacific Professional, and ConvaTec- A Bristol Myers Squibb Company.

    Joe holds a Bachelor of Arts degree from St. Lawrence University.

    Peg Beavers

    Executive Vice President

    Peg Beavers is Biocoat’s Executive Vice President. Peg is responsible for all aspects of order fulfillment, customer service and facility operations. Peg joined Biocoat in 2011 after accumulating over 10 years of experience in customer service, management and sales positions at Alstin Communications, Sprint Nextel, Pitney Bowes and AIWA America.

    Peg holds a Bachelor’s degree in Psychology from Allentown College of St. Francis de Sales (present day DeSales University).

    Steven Bell

    Chief Financial Officer

    Steven (Steve) Bell is Biocoat’s Chief Financial Officer. As CFO, Steve provides executive oversight of Biocoat’s financial and technology functions. Steven joined Biocoat in 2019 and brings 35 years of business experience that he obtained while working as a Certified Public Accountant and also as a CFO at ReSearch Pharmaceutical Services, CareScience, The MRC Group, and as a consultant providing outsourced CFO services for various middle market companies.

    Steve received a Bachelor of Business Administration (BBA), Accounting from Temple University.

    Jim Moran

    President & CEO

    Jim Moran is the President and CEO of Biocoat, Inc, a position he has held since 2018. Jim has been in the medical industry for over 25 years in various leadership, sales and marketing roles in both domestic and international assignments. Prior to joining Biocoat, he worked at Bracco Diagnostics, Acclarent, ConvaTec, TaylorMade-adidas Golf, Songbird Hearing and Vistakon. Jim also founded his own privately held medical device company called Jazz Medical in 2012 to provide advanced wound care products to the veterinary market.

    Jim received a Master of Business Administration from the University of Phoenix and a Bachelor of Science in Marketing from St. Joseph’s University in Philadelphia.